Ping An Lenovo Smart Healthcare and Fresenius Medical Care Launch Joint Venture to Develop Next-Generation Intelligent Dialysis Information System

Recently, Ping An Lenovo Smart Healthcare and Fresenius Medical Care held a signing ceremony in Shanghai, announcing the official establishment of their joint venture, Senrui Software Systems (Shanghai) Co., Ltd. (hereinafter referred to as “Senrui Software”).

Leveraging the technological strengths of Ping An Lenovo Smart Healthcare and Fresenius Medical Care’s extensive expertise in nephrology, the joint venture is committed to driving innovation to establish a more standardized, scientific, efficient, and intelligent ecosystem in the hemodialysis market, creating a leading one-stop solution for nephrology management across China. Attendees at the signing ceremony included Lin Lin, President of Ping An Lenovo Smart Healthcare and Chairman of Senrui Software; Chen Yugang, President of Fresenius Medical Care Greater China; Xie Shuyun and Yuan Tao, Directors of Senrui Software; and Zhuo Fuhui, General Manager of Senrui Software, among other executives.

According to VCBeat, the next-generation smart dialysis information system developed by the joint venture offers four key advantages:

First, Standards and Heritage: The new system is a software platform developed in compliance with and inheriting Fresenius’s global medical software R&D standard framework. It inherits and integrates the TDMS system, which embodies the German Fresenius Software R&D Center’s deep understanding of dialysis operations. Building upon the TDMS system, it adheres to Fresenius Germany’s software R&D quality management and standards, while leveraging Ping An Lenovo Smart Healthcare’s accumulated expertise in cutting-edge healthcare IT technologies to comprehensively address the specific needs of customers in the Chinese market;

Second, seamless connectivity of data devices: The new system is capable of fully and seamlessly connecting with Fresenius dialysis treatment equipment, thereby enhancing the comprehensive quality control level of dialysis medical services through a closed-loop data system;

Third, enhancement of efficiency and management: This is a cross-disciplinary collaborative product. Through cross-sector technological and business exchanges, we have optimized workflows and enabled real-time management via information systems, comprehensively improving the operational efficiency for healthcare professionals and the overall management of dialysis services.

Fourth, Enhancement of Intelligence: Building on the aforementioned foundations, the new system will continuously integrate the parent company’s accumulated expertise in emerging technologies such as big data, 5G, and artificial intelligence, thereby achieving the ultimate goal of smart dialysis.

Currently, while hemodialysis services have been effectively implemented nationwide for the treatment of kidney disease, the entire hemodialysis sector still lacks a comprehensive one-stop solution that meets the needs of patients, physicians, and nurses amidst the technological wave driven by intelligent transformation. Such a solution would effectively enable functionalities and applications including patient operations management, comprehensive tracking of the dialysis process, healthcare staff management, inventory control of pharmaceuticals and consumables, and big data analytics.

Ping An Lenovo Smart Healthcare has accumulated profound technological expertise in the field of medical technology, while Fresenius Medical Care is a global leader in providing products and services for patients with chronic renal failure. Through this strategic partnership between two industry leaders, Ping An Lenovo will provide technical development, and Fresenius Medical Care will offer standardized and regulated operational guidance for nephrology dialysis. Focusing on the integration of information systems, both parties aim to facilitate more efficient management for dialysis institutions, thereby meeting the growing diagnostic and treatment needs of patients with kidney diseases.

Lin Lin, CEO of Ping An Lenovo Smart Healthcare, stated that the joint venture aims to leverage the expertise and technological accumulation of its two parent companies to create a next-generation smart dialysis information system. The joint venture will enable Fresenius Medical Care in China not only to provide globally leading dialysis products and services but also to offer advanced, comprehensive smart dialysis management and service information systems, delivering turnkey solutions for nephrology medical institutions in China.

Lin Lin, CEO of Ping An Smart Healthcare

Chen Yugang, President of Fresenius Medical Care Greater China, stated that sustainable growth is our strategic objective. Every day, we are committed to creating a valuable future for dialysis patients worldwide. Through this collaboration with Ping An Lenovo Smart Healthcare, we aim to continuously improve the quality of life for kidney disease patients by leveraging innovative product solutions and superior treatment concepts.

Chen Yugang, President of Fresenius Medical Care Greater China

At the signing ceremony, Xie Shuyun, Director of Senrui Software, and Zhuo Fuhui, General Manager of Senrui Software, delivered speeches. Zhuo Fuhui stated, “In the near future, we will leverage Ping An Lenovo Smart Healthcare’s technical advantages and experience in smart hospital construction. Building upon Fresenius Medical Care’s Dialysis Treatment Data Management System (TDMS) and integrating solutions for various peripheral access devices, we will jointly develop a comprehensive solution. This will enable the Senrui Dialysis Management System to better serve the clinical diagnosis, treatment, and management needs of nephrology specialties.”

Xie Shuyun, Director of Senrui Software

Zhuo Fuhui, General Manager of Senrui Software

It is understood that this solution will leverage data advantages to optimize and improve the diagnostic and treatment processes of dialysis, ensure the safety and quality of hemodialysis therapy, enhance standardized and efficient management of dialysis, and achieve mobile, intelligent, and paperless dialysis operations. Meanwhile, it aims to help patients establish medical awareness regarding standardized treatment, scientific lifestyle, and rational medication use, thereby facilitating chronic disease management in nephrology departments.

In post-conference media interviews, guests stated that the new system, built in accordance with and inheriting Fresenius Medical Care’s global standards for medical software R&D, leverages Ping An Lenovo Smart Healthcare’s accumulated expertise in cutting-edge healthcare IT technologies. It comprehensively addresses the specific needs of customers in the Chinese market, ensures seamless connectivity of data and devices, significantly enhances efficiency, and enables smarter management.

It is worth noting that chronic kidney disease (CKD) is a highly significant condition among chronic diseases. The introduction of this solution makes it possible to leverage data intelligence, combined with the living environments and clinical data of CKD patients, to provide precise, human-centric, full-cycle care services for individuals with chronic kidney disease.

Ping An Lenovo Smart Healthcare is a core entity under Ping An Group and Lenovo Group, specializing in healthcare informatization. Formerly known as Lenovo Smart Healthcare, which was established in 2016, the company provides comprehensive hospital core business systems. From a top-level design perspective, it adopts a patient-centric approach, aims to enhance the work efficiency of medical staff, and establishes a closed-loop data quality control management system. By continuously optimizing and transforming hospital business processes, it improves the quality of diagnosis and treatment services. Ping An Lenovo Smart Healthcare is committed to delivering best-in-class integrated solutions to more medical institutions, providing robust support for informatization and business optimization in the healthcare sector, thereby leading the transformation towards informatization and intelligence in China’s healthcare industry.

Fresenius Medical Care is a global leader in the supply of blood purification therapy products, such as dialysis machines and dialyzers. In addition, Fresenius Medical Care is committed to providing high-quality medical services related to dialysis, regularly delivering renal care to over 3.4 million kidney disease patients worldwide. As of 2018, Fresenius Medical Care operated 3,928 hemodialysis centers globally, providing 50 million high-quality dialysis treatments to 333,000 patients. The company is currently listed on the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS).